Risk factors for local recurrence of large gastrointestinal lesions after endoscopic mucosal resection.


Journal

Techniques in coloproctology
ISSN: 1128-045X
Titre abrégé: Tech Coloproctol
Pays: Italy
ID NLM: 9613614

Informations de publication

Date de publication:
07 2022
Historique:
received: 20 06 2021
accepted: 18 04 2022
pubmed: 3 5 2022
medline: 10 6 2022
entrez: 2 5 2022
Statut: ppublish

Résumé

Endoscopic mucosal resection (EMR) is the primary treatment modality for superficial gastrointestinal mucosal lesions > 2 cm. However, the procedure carries some risk of complications including bleeding, perforation, and local recurrence. This study aimed to examine factors associated with EMR outcomes, especially in terms of local recurrence. This study retrospectively evaluated patients who underwent EMR and full closure with prophylactic clips for upper and lower gastrointestinal lesions > 2 cm at Cleveland Clinic Florida, between January 2013 and December 2018 with follow-up endoscopic evaluation for recurrence. A total of 2031 endoscopic polypectomy cases were examined; 307 EMR procedures among 271 patients (52% were female, mean age 65.6 ± 11.1 years) who satisfied the inclusion criteria were included in the study. There were no perforations reported. The rate of post-polypectomy delayed bleeding was 1.6%, and the local recurrence rate in this cohort was 7.1%. Recurrent cases were successfully endoscopically managed. In the multivariate regression analysis, age > 70 years (OR = 3.20, 95% CI 1.17-8.76, p = .023), body mass index (OR = 1.12, 95% CI 1.03-1.23 p = .008), and lesion size ≥ 35 mm (OR = 11.51, 95% CI 3.54-37.40, p =  < .001) were independent predictors for recurrence. Age > 70 years, increased lesion size, and obesity were found to be independent predictors of local recurrence among EMR procedures for gastrointestinal lesions > 2 cm. However, there is a need for larger-scale studies on this topic.

Sections du résumé

BACKGROUND
Endoscopic mucosal resection (EMR) is the primary treatment modality for superficial gastrointestinal mucosal lesions > 2 cm. However, the procedure carries some risk of complications including bleeding, perforation, and local recurrence. This study aimed to examine factors associated with EMR outcomes, especially in terms of local recurrence.
METHODS
This study retrospectively evaluated patients who underwent EMR and full closure with prophylactic clips for upper and lower gastrointestinal lesions > 2 cm at Cleveland Clinic Florida, between January 2013 and December 2018 with follow-up endoscopic evaluation for recurrence.
RESULTS
A total of 2031 endoscopic polypectomy cases were examined; 307 EMR procedures among 271 patients (52% were female, mean age 65.6 ± 11.1 years) who satisfied the inclusion criteria were included in the study. There were no perforations reported. The rate of post-polypectomy delayed bleeding was 1.6%, and the local recurrence rate in this cohort was 7.1%. Recurrent cases were successfully endoscopically managed. In the multivariate regression analysis, age > 70 years (OR = 3.20, 95% CI 1.17-8.76, p = .023), body mass index (OR = 1.12, 95% CI 1.03-1.23 p = .008), and lesion size ≥ 35 mm (OR = 11.51, 95% CI 3.54-37.40, p =  < .001) were independent predictors for recurrence.
CONCLUSIONS
Age > 70 years, increased lesion size, and obesity were found to be independent predictors of local recurrence among EMR procedures for gastrointestinal lesions > 2 cm. However, there is a need for larger-scale studies on this topic.

Identifiants

pubmed: 35499748
doi: 10.1007/s10151-022-02623-y
pii: 10.1007/s10151-022-02623-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

545-550

Informations de copyright

© 2022. Springer Nature Switzerland AG.

Références

Barendse RM, Musters GD, de Graaf EJR et al (2018) Randomised controlled trial of transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND Study). Gut 67:837–846
doi: 10.1136/gutjnl-2016-313101 pubmed: 28659349
Ferlitsch M, Moss A, Hassan C et al (2017) Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy 49:270–297
doi: 10.1055/s-0043-102569 pubmed: 28212588
Luba D, Raphael M, Zimmerman D et al (2017) Clipping prevents perforation in large, flat polyps. World J Gastrointest Endosc 9:133–138
doi: 10.4253/wjge.v9.i3.133 pubmed: 28360975 pmcid: 5355760
Parra-Blanco A, Kaminaga N, Kojima T et al (2000) Hemoclipping for postpolypectomy and postbiopsy colonic bleeding. Gastrointest Endosc 51:37–41
doi: 10.1016/S0016-5107(00)70384-1 pubmed: 10625793
Holmes I, Friedland S (2016) Endoscopic mucosal resection versus endoscopic submucosal dissection for large polyps: a western colonoscopist’s view. Clin Endosc 49:454–456
doi: 10.5946/ce.2016.077 pubmed: 27561263 pmcid: 5066401
Fujiya M, Tanaka K, Dokoshi T et al (2012) Efficacy and adverse events of EMR and endoscopic submucosal dissection for the treatment of colon neoplasms: a meta-analysis of studies comparing EMR and endoscopic submucosal dissection. Gastroint Endosc 81:583–595
doi: 10.1016/j.gie.2014.07.034
Ortiz AM, Bhargavi P, Zuckerman MJ, Othman MO (2014) Endoscopic mucosal resection recurrence rate for colorectal lesions. Southern Med J 107:615–621
doi: 10.14423/SMJ.0000000000000180 pubmed: 25279863
Kandel P, Wallace MB (2017) Colorectal endoscopic mucosal resection (EMR). Best Pract Res Clin Gastroenterol 31:455–471
doi: 10.1016/j.bpg.2017.05.006 pubmed: 28842056
Law R, Das A, Gregory D et al (2016) Endoscopic resection is cost-effective compared with laparoscopic resection in the management of complex colon polyps: an economic analysis. Gastrointest Endosc 83:1248–1257
doi: 10.1016/j.gie.2015.11.014 pubmed: 26608129
Ayoub F, Westerveld DR, Forde JJ et al (2019) Effect of prophylactic clip placement following endoscopic mucosal resection of large colorectal lesions on delayed polypectomy bleeding: A meta-analysis. World J Gastroenterol 25:2251–2263
doi: 10.3748/wjg.v25.i18.2251 pubmed: 31143075 pmcid: 6526150
Albéniz E, Álvarez MA, Espinós JC et al (2019) Clip closure after resection of large colorectal lesions with substantial risk of bleeding. Gastroenterology 157:1213–1221
doi: 10.1053/j.gastro.2019.07.037 pubmed: 31362007
Seo M, Song EM, Kim GU et al (2017) Local recurrence and subsequent endoscopic treatment after endoscopic piecemeal mucosal resection with or without precutting in the colorectum. Intest Res 15:502–510
doi: 10.5217/ir.2017.15.4.502 pubmed: 29142518 pmcid: 5683981
Moss A, Williams SJ, Hourigan LF et al (2015) Long-term adenoma recurrence following wide-field endoscopic mucosal resection (WF-EMR) for advanced colonic mucosal neoplasia is infrequent: results and risk factors in 1000 cases from the Australian Colonic EMR (ACE) study. Gut 64:57–65
doi: 10.1136/gutjnl-2013-305516 pubmed: 24986245
Tate DJ, Desomer L, Klein A et al (2017) Adenoma recurrence after piecemeal colonic EMR is predictable: the Sydney EMR recurrence tool. Gastrointest Endosc 85:647-656.e6
doi: 10.1016/j.gie.2016.11.027 pubmed: 27908600
Komeda Y, Watanabe T, Sakurai T et al (2019) Risk factors for local recurrence and appropriate surveillance interval after endoscopic resection. World J Gastroenterol 25:1502–1512
doi: 10.3748/wjg.v25.i12.1502 pubmed: 30948913 pmcid: 6441916
Belderbos TDG, Leenders M, Moons LMG, Siersema PD (2014) Local recurrence after endoscopic mucosal resection of nonpedunculated colorectal lesions: systematic review and meta-analysis. Endoscopy 46:388–402
doi: 10.1055/s-0034-1364970 pubmed: 24671869
Brenner H, Hoffmeister M, Stegmaier C et al (2007) Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut 56:1585–1589
doi: 10.1136/gut.2007.122739 pubmed: 17591622 pmcid: 2095643
Ning Y, Wang L, Giovannucci EL (2010) A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev 11:19–30
doi: 10.1111/j.1467-789X.2009.00613.x pubmed: 19538439
Wang F-W, Hsu P-I, Chuang H-Y et al (2014) Prevalence and risk factors of asymptomatic colorectal polyps in Taiwan. Gastroenterol Res Pract. https://doi.org/10.1155/2014/985205
doi: 10.1155/2014/985205 pubmed: 25614737 pmcid: 4295351
Hao Y, Wang Y, Qi M et al (2020) Risk factors for recurrent colorectal polyps. Gut Liver 14:399–411
doi: 10.5009/gnl19097 pubmed: 31547641
Renehan AG, Tyson M, Egger M et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578
doi: 10.1016/S0140-6736(08)60269-X pubmed: 18280327
Anderson JC, Messina CR, Dakhllalah F et al (2007) Body mass index: a marker for significant colorectal neoplasia in a screening population. J Clin Gastroenterol 41:285–290
doi: 10.1097/01.mcg.0000247988.96838.60 pubmed: 17426468
Murphy TK (2000) Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 152:847–854
doi: 10.1093/aje/152.9.847 pubmed: 11085396
Giovannucci E (2002) Obesity, gender, and colon cancer. Gut 51:147
doi: 10.1136/gut.51.2.147 pubmed: 12117867 pmcid: 1773303
Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3:565–574
doi: 10.1016/S1470-2045(02)00849-5 pubmed: 12217794
Almendingen K, Hofstad B, Vatn MH (2001) Does high body fatness increase the risk of presence and growth of colorectal adenomas followed up in situ for 3 years? Am J Gastroenterol 96:2238–2246
doi: 10.1111/j.1572-0241.2001.03942.x pubmed: 11467659
Betés M, Muñoz-Navas MA, Duque JM et al (2003) Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol 98:2648–2654
pubmed: 14687811

Auteurs

Yasar Colak (Y)

Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic Florida, Weston, FL, USA.
Department of Gastroenterology, School of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.

Badar Hasan (B)

Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic Florida, Weston, FL, USA.

Walid Hassaballa (W)

Department of Colorectal Surgery, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.

Mamoon Ur Rashid (M)

Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic Florida, Weston, FL, USA.

Victor Strassmann (V)

Department of Colorectal Surgery, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.

Giovanna DaSilva (G)

Department of Colorectal Surgery, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.

Steven D Wexner (SD)

Department of Colorectal Surgery, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA. wexners@ccf.org.

Tolga Erim (T)

Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic Florida, Weston, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH